electroCore, Inc. Earnings Recaps
Q3 2025
Nov 7, 2025
electroCore's Q3 2025 results reflect a strategic pivot aimed at accelerating growth through key investments and acquisitions, despite a temporary delay in profitability.
Key takeaways
- Delivered robust revenue growth in the VA channel, secured a new 5-year contract, and expanded sales capabilities.
- Acquired NeuroMetrix's Quell portfolio, enhancing product offerings and diversifying revenue streams with a new FDA-cleared device for fibromyalgia.
- Initiated targeted investments in technology and personnel to support growth in both medical and wellness divisions, positioning the company for future success.